Stay updated on Belantamab vs Bortezomib in MM Clinical Trial
Sign up to get notified when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.
Latest updates to the Belantamab vs Bortezomib in MM Clinical Trial page
- Check5 days agoChange DetectedThe page footer revision label updated from v3.3.1 to v3.3.2, with no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check12 days agoChange DetectedThe page adds a note that publications are automatically filled from PubMed and updates the revision tag to v3.3.1. No substantive study information is changed.SummaryDifference0.1%
- Check20 days agoChange DetectedAdded a citation for the DREAMM-8 publication in Lancet Haematol 2025 detailing patient-reported outcomes. Removed a generic government funding notice that does not affect the study content.SummaryDifference0.2%
- Check34 days agoChange DetectedChanges appear limited to UI/layout tweaks and do not affect core study content such as arms, endpoints, enrollment, or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check55 days agoChange DetectedAdded new MedlinePlus Genetics topic on Multiple myeloma, expanding core content related to genetics of a specific disease.SummaryDifference0.1%
- Check63 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference2%
Stay in the know with updates to Belantamab vs Bortezomib in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.